Efficacy and effectiveness of robot-assisted therapy for autism spectrum disorder: From lab to reality.

Researchers tested robot therapy for young children with autism in two studies. The first study found that 12 sessions of robot therapy at a clinic worked just as well as regular therapy, but children were more engaged. The second study used a simpler robot setup that could work in schools or homes, needing only 5 sessions to get similar results to standard therapy. Both studies show robot therapy can be as effective as traditional approaches while potentially being more engaging for children.

This study presents two randomized controlled trials evaluating robot-assisted therapy for autism in children aged 4-6 years. The first efficacy trial (n=69) compared 12 biweekly sessions of in-clinic robot-assisted therapy to conventional treatment, finding equivalent outcomes but with significantly increased patient engagement. The second effectiveness trial (n=63) tested a simplified robot setup suitable for schools/homes over 5 sessions, also showing equivalent outcomes to standard treatment. Both trials targeted core developmental mechanisms including joint attention, imitation, and turn-taking.

The research bridges laboratory findings with real-world application, demonstrating that robot-assisted therapy can match conventional approaches while offering potential advantages in engagement and cost-effectiveness through portable setups.

Robot-assisted therapy shows promise as an effective alternative to conventional autism interventions, with potential advantages in engagement and accessibility. The development of portable, simplified setups could make this technology more widely available in schools and homes, potentially reducing costs and improving access to therapy.

The abstract does not specify outcome measures used, duration of follow-up, or specific domains improved. Sample sizes are relatively small for definitive conclusions. Details about randomization, blinding procedures, and potential conflicts of interest are not provided.

The use of social robots in therapy for children with autism has been explored for more than 20 years, but there still is limited clinical evidence. The work presented here provides a systematic approach to evaluating both efficacy and effectiveness, bridging the gap between theory and practice by targeting joint attention, imitation, and turn-taking as core developmental mechanisms that can make a difference in autism interventions. We present two randomized clinical trials with different robot-assisted therapy implementations aimed at young children. The first is an efficacy trial ( = 69; mean age = 4.4 years) showing that 12 biweekly sessions of in-clinic robot-assisted therapy achieve equivalent outcomes to conventional treatment but with a significant increase in the patients' engagement.

The second trial ( = 63; mean age = 5.9 years) evaluates the effectiveness in real-world settings by substituting the clinical setup with a simpler one for use in schools or homes. Over the course of a modest dosage of five sessions, we show equivalent outcomes to standard treatment. Both efficacy and effectiveness trials lend further credibility to the beneficial role that social robots can play in autism therapy while also highlighting the potential advantages of portable and cost-effective setups.